Glutamate Receptor 1 Antikörper (N-Term)
Kurzübersicht für Glutamate Receptor 1 Antikörper (N-Term) (ABIN927672)
Target
Alle Glutamate Receptor 1 (GLUR1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Maus
-
Aufreinigung
- Purified
-
Immunogen
- GRIA1 antibody was raised in rabbit using the N terminal of GRIA1 as the immunogen
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator.
-
Kommentare
-
GRIA1 Blocking Peptide, (ABIN937076), is also available for use as a blocking control in assays to test for specificity of this GRIA1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Glutamate Receptor 1 (GLUR1)
-
Andere Bezeichnung
- GRIA1
-
Hintergrund
- Gria1 is an ionotropic glutamate receptor. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate. Synonyms: Polyclonal Gria1 antibody, Anti-Gria1 antibody, glutamate receptor, ionotropic, AMPA1, alpha 1 antibody, 2900051M01Rik antibody, AI853806 antibody, Glr-1 antibody, Glr1 antibody, GluR-A antibody, GluRA antibody, Glur-1 antibody, Glur1 antibody, HIPA1 antibody.
-
Pathways
- PI3K-Akt Signalweg
Target
-